Janssen Search
Search results
Recognizing World Cancer Day 2018 with Cancer.com
Recognizing World Cancer Day 2018 with Cancer.com At Janssen Oncology, we envision a world where cancer is a preventable, chronic, or curable disease. To achieve victories over cancer, we’re focused on developing resources that are designed to help ...
The Amazing Scientists at the Forefront of HIV Research
The Amazing Scientists at the Forefront of HIV Research Jul 19, 2018 Article Type: Infectious Diseases & Vaccines ...
Janssen Presents Longer-Term Talquetamab Follow-Up Data Showing Overall Response Rates of More Than 70 Percent in Heavily Pretreated Patients with Multiple Myeloma
Jun 03, 2023 United States Additional long-term data from the TRiMM-2 study in patients receiving talquetamab and DARZALEX FASPRO ® combination biweekly regimen showed an overall response rate of more than 80 percent CHICAGO, June 3, 2023 – The Janssen ...
JANSSEN POSTDOCTORAL PROGRAM
Gain experience in a world-class scientific setting while developing the skills necessary to position yourself for success in the pharmaceutical industry and/or academia. Language English ...
Janssen Global Clinical Trial Finder
Janssen Global Clinical Trial Finder Nov 22, 2016 Helping Others by Contributing To Medical Research Article Type: Clinical Trials ...
Oncology – Overview
We envision a world where cancer is a preventable, chronic or curable disease. To get there, we’re focused on developing solutions that prolong and improve patient lives. Article Type: Oncology ...
MINING
Sep 02, 2020 Article Block Text: the universe of real-world data (RWD)*, drawn from existing sources or newly captured from patients’ lived experience, to drive accelerated discovery and development. ...
First results from late-breaking Phase 3 PALOMA-3 study show five-fold reduction in infusion-related reactions with five-minute subcutaneous amivantamab administration
May 31, 2024 New formulation showed non-inferiority to intravenous administration in fourth positive Phase 3 study in RYBREVANT® clinical program Longer overall survival, progression-free survival and duration of response shown with subcutaneous ...
The Microbiome: A New Research Tool
The Microbiome: A New Research Tool Jan 06, 2017 Article Block Text: PharmaVoice – March 2016 Redirect URL: http://www.pharmavoice.com/article/2016-03-microbiome ...
Oncology – Overview
Apr 07, 2015 We envision a world where cancer is a preventable, chronic or curable disease. To get there, we’re focused on developing solutions that prolong and improve patient lives. Article Type: Oncology ...